Company News / by Lauren Evans - 2 years ago Imugene (ASX:IMU) secures deal to evaluate its cancer vaccine 16 Nov 2021 - Bio-tech company Imugene (ASX: IMU) has announced a new clinical trial supply agreement to evaluate the safety and efficiency of Imugene’s HER-Vaxx, a therapeutic can…
